TAXUS I: six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
E Grube, S Silber, KE Hauptmann, R Mueller… - Circulation, 2003 - Am Heart Assoc
Background—The TAXUS NIRx stent (Boston Scientific Corp) provides local delivery of
paclitaxel via a slow-release polymer coating. The TAXUS I trial was the first in-human …
paclitaxel via a slow-release polymer coating. The TAXUS I trial was the first in-human …
Transcatheter aortic valve implantation: first results from a multi-centre real-world registry
R Zahn, U Gerckens, E Grube, A Linke… - European heart …, 2011 - academic.oup.com
Aims Treatment of elderly symptomatic patients with severe aortic stenosis and co-
morbidities is challenging. Transcatheter aortic valve interventions [balloon valvuloplasty …
morbidities is challenging. Transcatheter aortic valve interventions [balloon valvuloplasty …
Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation
PB Sick, G Schuler, KE Hauptmann, E Grube… - Journal of the American …, 2007 - jacc.org
Objectives: This study assessed the feasibility of implanting a device in the left atrial
appendage (LAA) in patients with atrial fibrillation (AF) to prevent thromboembolic stroke …
appendage (LAA) in patients with atrial fibrillation (AF) to prevent thromboembolic stroke …
Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve
J Schofer, A Colombo, S Klugmann, J Fajadet… - Journal of the American …, 2014 - jacc.org
Objectives: The study sought a prospective multicenter nonrandomized evaluation of the
Direct Flow Medical (DFM) system for the treatment of severe aortic stenosis. Background …
Direct Flow Medical (DFM) system for the treatment of severe aortic stenosis. Background …
Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI …
T Bauer, A Linke, H Sievert, P Kahlert… - The American journal of …, 2014 - Elsevier
Patients with bicuspid aortic valves (BAVs) are considered a relative contraindication to
transcatheter aortic valve implantation (TAVI). One of the main reasons is the presumed risk …
transcatheter aortic valve implantation (TAVI). One of the main reasons is the presumed risk …
A multicenter randomized trial comparing amphilimus-with paclitaxel-eluting stents in de novo native coronary artery lesions
D Carrié, J Berland, S Verheye, KE Hauptmann… - Journal of the American …, 2012 - jacc.org
Objectives: This study sought to demonstrate the noninferiority of polymer-free amphilimus-
eluting stents (Cre8, CID, Saluggia, Italy) versus permanent-polymer paclitaxel-eluting stents …
eluting stents (Cre8, CID, Saluggia, Italy) versus permanent-polymer paclitaxel-eluting stents …
Embolic protection devices for carotid artery stenting: better results than stenting without protection?
R Zahn, B Mark, N Niedermaier, U Zeymer… - European heart …, 2004 - academic.oup.com
Aims Carotid artery stenting (CAS) for carotid artery stenoses has become an alternative to
carotid endarterectomy. However, CAS itself can cause cerebral ischaemic events. Embolic …
carotid endarterectomy. However, CAS itself can cause cerebral ischaemic events. Embolic …
Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry
R Zahn, T Ischinger, M Hochadel, U Zeymer… - European heart …, 2007 - academic.oup.com
Aims We tried to determine the influence of age on complication rates of carotid artery
stenting (CAS). Methods and results Two thousand seven hundred eighty CAS procedures …
stenting (CAS). Methods and results Two thousand seven hundred eighty CAS procedures …
The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve …
JM Sinning, M Horack, E Grube, U Gerckens… - American heart …, 2012 - Elsevier
BACKGROUND: A significant proportion of patients undergoing transcatheter aortic valve
implantation (TAVI) have concomitant peripheral arterial disease (PAD), which plays a …
implantation (TAVI) have concomitant peripheral arterial disease (PAD), which plays a …
[HTML][HTML] Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9 eluting stent with a biodegradable polymer coating
E Grube, KE Hauptmann… - …, 2005 - eurointervention.pcronline.com
Objectives: The STEALTH (STent Eluting A9 BioLimus Trial in Humans) trial was the first-in-
man study to assess the safety and efficacy of the bioabsorbable-polymer-coated Biolimus …
man study to assess the safety and efficacy of the bioabsorbable-polymer-coated Biolimus …